Physician profile
Haley Bunting
NPI 1609262690
$7,244.01
in general payments reported to CMS, 2019-2025
12 companies · $2,514 in 2025
The $2,514 reported for 2025 was more than what 86% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $417 · 2023: $3,243 · 2024: $1,070 · 2025: $2,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,857 · Travel and Lodging: $1,770 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,856.87 |
| Travel and Lodging | $1,769.85 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,031.01 | 2023 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Rti Surgical, INC | $1,200.00 | 2025 | |
| Mentor Worldwide LLC | $1,104.55 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Abbvie INC. | $841.34 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Stryker Corporation | $614.99 | 2022-2025 | Spy-Phi System, Dermacell |
| Davol INC. | $379.57 | 2022-2024 | Phasix Mesh |
| Tela Bio, INC. | $332.39 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $224.37 | 2023-2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Musculoskeletal Transplant Foundation INC. | $185.82 | 2023-2025 | |
| Allergan, INC. | $166.51 | 2022 | |
| Biocircuit Technologies INC | $150.70 | 2025 | Nerve Tape |
| Kci USA, INC. | $12.76 | 2023 | Prevena, Prevena Restor Bellaform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Bunting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.